Maron et al evaluated patients with hypertrophic cardiomyopathy. They identified risk factors for severe symptoms or death which can help to identify a patient who may benefit from more aggressive management. The authors are from Tufts-New England Medical Center, Azienda Ospedaliera Careggi (Florence), Federico II University of Naples, and the Minneapolis Heart Institute Foundation.